These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Evaluation of non-invasive scores in the follow-up of chronic hepatitis]. Klein C; Gerken G Praxis (Bern 1994); 2005 Apr; 94(16):645-7. PubMed ID: 15900828 [TBL] [Abstract][Full Text] [Related]
9. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Regev A; Berho M; Jeffers LJ; Milikowski C; Molina EG; Pyrsopoulos NT; Feng ZZ; Reddy KR; Schiff ER Am J Gastroenterol; 2002 Oct; 97(10):2614-8. PubMed ID: 12385448 [TBL] [Abstract][Full Text] [Related]
10. [Role of liver biopsy in chronic hepatitis C]. Aguirre García J Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S27-8. PubMed ID: 12712849 [TBL] [Abstract][Full Text] [Related]
11. Histological scoring of fibrosis and activity in HIV-chronic hepatitis B related liver disease: performance of the METAVIR score assessed on virtual slides. Wendum D; Lacombe K; Chevallier M; Callard P; Valet F; Miailhes P; Bonnard P; Molina JM; Lascoux-Combe C; Fléjou JF; Girard PM J Clin Pathol; 2009 Apr; 62(4):361-3. PubMed ID: 19126564 [TBL] [Abstract][Full Text] [Related]
13. [Differential diagnosis and staging of chronic nonsuppurative destructive cholangitis in liver biopsies]. Kunze KD; Kobe E Zentralbl Allg Pathol; 1986; 132(3):223-32. PubMed ID: 3788315 [TBL] [Abstract][Full Text] [Related]
14. A scoring system for predicting significant fibrosis in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase levels. Wang H; Yan R; Zhou Y; Wang MS; Ruo GQ; Cheng MJ J Clin Gastroenterol; 2015 Jan; 49(1):69-75. PubMed ID: 24518795 [TBL] [Abstract][Full Text] [Related]
15. Grade and stage in chronic hepatitis. Jevon GP Pediatr Dev Pathol; 2001; 4(4):372-80. PubMed ID: 11441339 [TBL] [Abstract][Full Text] [Related]
16. [A proposition for a histopathologic examination protocol of liver biopsy in diagnosis of chronic hepatitis]. Gabriel A; Ziółkowski A Pol Merkur Lekarski; 1997 May; 2(11):320-3. PubMed ID: 9377681 [TBL] [Abstract][Full Text] [Related]
17. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring. Elesawy BH; Abd El Hafez A; Dorgham LS; El-Askary A Pathol Res Pract; 2014 Dec; 210(12):922-8. PubMed ID: 25123964 [TBL] [Abstract][Full Text] [Related]
18. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. Goodman ZD J Hepatol; 2007 Oct; 47(4):598-607. PubMed ID: 17692984 [TBL] [Abstract][Full Text] [Related]
19. [Is liver biopsy the gold standard for assessment of liver fibrosis?]. Hu XQ Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):568-70. PubMed ID: 23227530 [No Abstract] [Full Text] [Related]
20. Sampling variability of liver fibrosis in chronic hepatitis C. Bedossa P; Dargère D; Paradis V Hepatology; 2003 Dec; 38(6):1449-57. PubMed ID: 14647056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]